S-Allylcysteine reduces breast tumor cell adhesion and invasion

Leslie A Gapter1, Ong Zhan Yuin, Ka-Yun Ng

  • 1Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Building S4, Singapore 117543, Republic of Singapore.

Insights

S-allylcysteine (SAC), a garlic derivative, inhibits breast tumor cell growth and invasion. It achieves this by altering cell adhesion and reducing key proteins involved in cancer metastasis, suggesting a potential therapeutic role.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aqueous garlic extract and S-allylcysteine (SAC) have shown promise in preventing breast cancer initiation.
  • Previous research on SAC's effects on later stages of breast tumorigenesis and metastasis yielded inconsistent results.

Purpose of the Study:

  • To investigate the impact of SAC on established breast tumor cell growth, invasion, and metastasis-related molecular mechanisms.
  • To determine if SAC affects anchorage-dependent and -independent growth of MDA-MB-231 breast cancer cells.

Main Methods:

  • Treatment of MDA-MB-231 breast tumor cells with varying doses and durations of SAC.
  • Assessment of cell growth, adhesion, and invasion assays.
  • Analysis of E-cadherin and Matrix Metalloproteinase-2 (MMP-2) expression and activity.

Main Results:

  • SAC significantly reduced both anchorage-dependent and -independent growth of MDA-MB-231 cells in a dose- and time-dependent manner.
  • Sub-lethal SAC treatment altered mammary tumor cell adhesion and invasion.
  • SAC increased E-cadherin expression and decreased MMP-2 expression and activity, contributing to reduced cell invasion.

Conclusions:

  • SAC effectively inhibits breast tumor cell growth and invasion, potentially by modulating extracellular matrix interactions.
  • Increased E-cadherin and reduced MMP-2 activity are key mechanisms by which SAC represses breast cancer cell motility and invasion.
  • These findings suggest SAC has the potential to inhibit key events in breast cancer metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...